|
2026 Journal Article Maximal motor unit firing rates decline with amyotrophic lateral sclerosis progressionFernandes, Gabriel L., Orssatto, Lucas B.R., Pinto, Matheus D., Henkin, Joao S., Shandiz, Ehsan, McCombe, Pamela A., Henderson, Robert D. and Trajano, Gabriel S. (2026). Maximal motor unit firing rates decline with amyotrophic lateral sclerosis progression. Clinical Neurophysiology, 185 2111697. doi: 10.1016/j.clinph.2026.2111697 |
|
2026 Journal Article Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum DisorderSiriratnam, Pakeeran, Jokubaitis, Vilija G., Van Der Walt, Anneke, Sanfilippo, Paul G., Zhu, Chao, Etemadifar, Masoud, Altintas, Ayse, Al-Asmi, Abdullah, Laureys, Guy, Meca-Lallana, Jose E., Foschi, Matteo, Alroughani, Raed, Gomez-Figueroa, Enrique, Habek, Mario, Khoury, Samia J., Simo, Magdolna, Singhal, Bhim Sen G., Jakob, Gregor Brecl, Fabis-Pedrini, Marzena J., Soysal, Aysun, Kermode, Allan G., Shaygannejad, Vahid, Kubala Havrdova, Eva, Millan-Pascual, Jorge, Roos, Izanne, Mccombe, Pamela Ann, Nytrova, Petra, Boz, Cavit, Surcinelli, Andrea ... Fatih Yetkin, Mehmet (2026). Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder. Neurology, 106 (7) e214707. doi: 10.1212/wnl.0000000000214707 |
|
2026 Journal Article Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort StudyRoos, Izanne, Sharmin, Sifat, Ozakbas, Serkan, Alroughani, Raed, Eichau, Sara, Grand'maison, Francois, Boz, Cavit, Lechner-Scott, Jeannette, Buzzard, Katherine, Prat, Alexandre, Khoury, Samia J., Grammond, Pierre, Van Der Walt, Anneke, Blanco, Yolanda, Foschi, Matteo, Soysal, Aysun, Barnett, Michael, Prevost, Julie, Terzi, Murat, Gerlach, Oliver, Macdonell, Richard, Sa, Maria Jose, Spitaleri, Daniele, Laureys, Guy, Van Pesch, Vincent, John, Nevin, Cartechini, Elisabetta, Gouider, Riadh, Maimone, Davide ... Kalincik, Tomas (2026). Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study. Cns Drugs. doi: 10.1007/s40263-026-01287-8 |
|
2026 Journal Article Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunitiesKhan, Nemat, Zakriya, Zikra M., McCombe, Pamela and Woodruff, Trent M. (2026). Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities. Trends in Pharmacological Sciences, 47 (4), 355-368. doi: 10.1016/j.tips.2026.02.006 |
|
2026 Journal Article Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosisHop, Paul J., Kooyman, Maarten, Kenna, Brendan J., Zwamborn, Ramona A. J., van Eijk, Kristel R., Wang, Yan, van Dijk, Charlotte H., Bekema, Erwin, van Rheenen, Wouter, Beele, Paul, van Vugt, Joke J. F. A., Al Khleifat, Ahmad, Iacoangeli, Alfredo, Cooper-Knock, Johnathan, Smith, Bradley N., Topp, Simon, van der Kooi, Anneke J., Fominykh, Vera, Drory, Vivian, Lerner, Yossef, Shovman, Yehuda, Rowe, Dominic B., Williams, Kelly L., McLaughlin, Russell L., Hurt, Jessica, Huang, Yunfeng, Chen, Chia-Yen, Tsai, Ellen, Runz, Heiko ... Veldink, Jan H. (2026). Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis. Nature Genetics, 58 (4), 717-725. doi: 10.1038/s41588-026-02535-9 |
|
2026 Journal Article Review of the pathology of muscle in amyotrophic lateral sclerosisKatz, Matthew, Robertson, Thomas, Ngo, Shyuan T., Yarlagadda, Sai, Henderson, Robert D., McCombe, Pamela A. and Noakes, Peter G. (2026). Review of the pathology of muscle in amyotrophic lateral sclerosis. International Journal of Molecular Sciences, 27 (6) 2802, 1-33. doi: 10.3390/ijms27062802 |
|
2026 Journal Article Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosisKalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S, Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Øivind, Bø, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, J William L, Coles, Alasdair, van der Walt, Anneke, Butzkueven, Helmut, Van Wijmeersch, Bart, Lechner-Scott, Jeannette, Barnett, Michael, Laureys, Guy, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga, Di Gregorio, Maria ... Snowden, John A (2026). Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis. Brain, 149 (3), 951-962. doi: 10.1093/brain/awaf286 |
|
2026 Conference Publication Cessation of anti-trafficking therapies after the age of 50 yearsMuller, Jannis, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan, Fabis-Pedrini, Marzena, Macdonell, Richard, Slee, Mark, Garber, Justin, Kuhle, Jens, Kappos, Ludwig, Amato, Maria Pia, Trojan, Maria, Kalincik, Tomas and Roos, Izanne (2026). Cessation of anti-trafficking therapies after the age of 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Causal effects of multiple sclerosis therapies in left-truncated registry dataHaile, Dagmawi, Diouf, Ibrahima, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Macdonell, Richard, Barnett, Michael, Shaw, Cameron, Massey, Jennifer, Hardy, Todd A., Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Hodgkinson, Suzanne, Garber, Justin, John, Nevin, Lechner-Scott, Jeannette, Slee, Mark, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., McCombe, Pamela, Foong, Yi Chao, Taylor, Bruce, Ferrando, Beatriz Romero, Stuart, Elizabeth, Sharmin, Sifat, Roos, Izanne and Kalincik, Tomas (2026). Causal effects of multiple sclerosis therapies in left-truncated registry data. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Bayesian networks to generate representative longitudinal data in multiple sclerosisQiang, Zhe, Iqbal, Hassam, Sharmina, Sifat, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeanette, John, Nevin, Buzzard, Katherine, Skibina, Olga, Barnett, Michael, Mccombe, Pamela, Hodgkinson, Suzanne, Macdonell, Richard, Slee, Mark, Hardy, Todd, Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Taylor, Bruce, Foong, Yi Chao, Garber, Justin, Field, Deborah, Malpas, Charles, Roos, Izanne and Kalincik, Tomas (2026). Bayesian networks to generate representative longitudinal data in multiple sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Long-term prognostic value of confirmed disability improvements in multiple sclerosisLizak, Nathaniel, Sharmin, Sifat, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Barnett, Michael, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., John, Nevin, Macdonell, Richard, Hodgkinson, Suzanne, Slee, Mark, McCombe, Pamela, Taylor, Bruce, Garber, Justin, Ferrando, Beatriz Romero, Mason, Deborah, Hardy, Todd, Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Massey, Jennifer, Shaw, Cameron, Field, Deborah, Shuey, Neil, Roos, Izanne and Kalincik, Tomas (2026). Long-term prognostic value of confirmed disability improvements in multiple sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Effectiveness of ocrelizumab in multiple sclerosis: a multi-registry cohort studyRoos, Izanne, Sharmin, Sifat, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Lechner-Scott, Jeannette, John, Nevin, Macdonell, Richard, Mccombe, Pamela, Hodgkinson, Suzanne, Kermode, Allan, Vukusic, Sandra, Magyari, Melinda, Laplaud, David and Kalincik, Tomas (2026). Effectiveness of ocrelizumab in multiple sclerosis: a multi-registry cohort study. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin, Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Girard, Marc ... Van Der Walt, Anneke (2026). Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Machine Learning-Generated Longitudinal Synthetic International Data in Multiple SclerosisIqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, Slee, Mark, Mccombe, Pamela, Taylor, Bruce, Foong, Yi Chao, Macdonell, Richard, Hardy, Todd A., Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Field, Deborah, Massey, Jennifer, Malpas, Charles, Roos, Izanne and Kalincik, Prof Tomas (2026). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset TimingSajedi, Seyed Aidin, Zhu, Chao, Abdollahi, Fahimeh, Saberi, Fatemeh, Horakova, Dana, Ozakbas, Serkan, Zakaria, Magd, Shaygannejad, Vahid, Etemadifar, Masoud, Khoury, Samia J., Weinstock-Guttman, Bianca, Patti, Francesco, Boz, Cavit, Eichau, Sara, Tomassini, Valentina, Terzi, Murat, Duquette, Pierre, Kermode, Allan G., Karelis, Guntis, Amato, Maria Pia, Libertinova, Jana, Grand'Maison, Francois, Shalaby, Nevin, Kalincik, Tomas, Buzzard, Katherine, Habek, Mario, Blanco, Yolanda, Grammond, Pierre, Lechner-Scott, Jeannette ... Butzkueven, Helmut (2026). Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Conference Publication Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 yearsMuller, Jannis, Buzzard, Kathrine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan G., Fabris-Pedrini, Marzena, Carroll, William M., Macdonell, Richard, Slee, Mark, Kuhle, Jens, Amato, Maria Pia, Trojano, Maria, Kalincik, Tomas and Roos, Izanne (2026). Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD. |
|
2026 Journal Article Systemic immune-metabolic interactions in patients with amyotrophic lateral sclerosis: correlations of plasma cytokines with metabolic statusHowe, Stephanie L., Holdom, Cory J., McCombe, Pamela A., Henderson, Robert D., Steyn, Frederik J. and Ngo, Shyuan T. (2026). Systemic immune-metabolic interactions in patients with amyotrophic lateral sclerosis: correlations of plasma cytokines with metabolic status. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-11. doi: 10.1080/21678421.2026.2627902 |
|
2026 Journal Article Autosomal recessive spastic ataxia of Charlevoix-Saguenay in two half-siblingsYeow, Dennis, Katz, Matthew, Rodgers, Jonathan, Davis, Mark, Robertson, Thomas, Gardner, R. J. McKinlay and McCombe, Pamela A. (2026). Autosomal recessive spastic ataxia of Charlevoix-Saguenay in two half-siblings. Annals of Clinical and Translational Neurology, 13 (2) acn3.70236, 413-417. doi: 10.1002/acn3.70236 |
|
2026 Journal Article Assessment of language and executive functions in ALS: the brief executive Language screenRobinson, Gail A., Phillips, Mia R., Horne, Kristina, Ceslis, Amelia, McCombe, Pamela A. and Henderson, Robert D. (2026). Assessment of language and executive functions in ALS: the brief executive Language screen. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-11. doi: 10.1080/21678421.2025.2607398 |
|
2026 Journal Article Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosisFoong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva Kubala, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas,, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia Joseph, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin, Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Girard, Marc ... Study Group, MSBase (2026). Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 97 (1) jnnp-2025-336513, 1-9. doi: 10.1136/jnnp-2025-336513 |
